| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |